Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.140
-0.090 (-4.04%)
At close: Feb 3, 2026, 4:00 PM EST
2.180
+0.040 (1.87%)
After-hours: Feb 3, 2026, 4:54 PM EST
Spero Therapeutics Market Cap
Spero Therapeutics has a market cap or net worth of $120.57 million as of February 3, 2026. Its market cap has increased by 164.98% in one year.
Market Cap
120.57M
Enterprise Value
75.30M
1-Year Change
164.98%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since November 2, 2017, Spero Therapeutics's market cap has decreased from $154.10M to $120.57M, a decrease of -21.76%. That is a compound annual growth rate of -2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 125.60M | -4.34% |
| Dec 31, 2025 | 131.30M | 133.63% |
| Dec 31, 2024 | 56.20M | -27.86% |
| Dec 29, 2023 | 77.90M | -13.06% |
| Dec 30, 2022 | 89.60M | -82.69% |
| Dec 31, 2021 | 517.50M | -1.84% |
| Dec 31, 2020 | 527.20M | 186.68% |
| Dec 31, 2019 | 183.90M | 64.34% |
| Dec 31, 2018 | 111.90M | -33.71% |
| Dec 29, 2017 | 168.80M | 9.54% |
| Nov 2, 2017 | 154.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 131.21M |
| Adagene | 129.61M |
| Unicycive Therapeutics | 128.30M |
| Sutro Biopharma | 127.36M |
| Whitehawk Therapeutics | 127.25M |
| Korro Bio | 125.53M |
| Turn Therapeutics | 121.31M |
| Karyopharm Therapeutics | 119.38M |